Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC - 2026
Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC
_Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments.pdf
[en] Abstract
Early detection of cancer and advances in treatment have significantly improved the survival rate of patients with cancer. Both cancer and its treatment can accelerate the onset of cardiovascular disease, adversely affecting prognosis of patients with cancer and survivors. Coronary artery disease (CAD) and peripheral artery disease (PAD) are common complications in patients with cancer. Cardiovascular imaging plays a central role in baseline risk assessment, detection, and treatment planning. The indications for the use of various imaging modalities are similar as in the general population. However, due to unique pathophysiological characteristics and clinical presentations of this population, the use of cardiac imaging in these vulnerable patients often needs to be adapted to the clinical circumstances and individual patient characteristics. In this clinical consensus statement, the European Society of Cardiology (ESC) Council of Cardio-Oncology and the European Association of Cardiovascular Imaging of the ESC have reviewed and summarized the current evidence in this field to aid clinicians in the selection of appropriate imaging modalities for the diagnosis, monitoring, and treatment of CAD and PAD in patients with cancer.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Novo, Giuseppina; Department of Health Promotion, Maternal and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy ; Division of Cardiology, University Hospital P. Giaccone, Palermo, Italy
Lopez-Fernandez, Teresa; Cardiology Department, La Paz University Hospital ; Idi PAZ Research Institute, Madrid, Spain
Delgado, Victoria; Heart Institute Hospital University Germans Trias i Pujol, Badalona, Spain ; Centre of Comparative Medicine and Bioimaging, Institute of Research Germans Trias i Pujol, Badalona, Spain
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Almeida, Ana; Faculty of Medicine, Heart and Vessels Department, Lisbon University, Cardiology ; CCUL@RISE, ULS Santa Maria, Lisbon, Portugal
Bergler-Klein, Jutta; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Celutkiene, Jelena; Department of Cardiac and Vascular Diseases, Faculty of Medicine, Centre of Innovative Medicine, Vilnius University, Vilnius, Lithuania
Dweck, Marc; BHF Centre for Cardiovascular Sciences, University of Edinburgh, Little France Crescent, Little France, Edinburgh, UK
Guglielmo, Marco; Division of Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands ; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands
Gulati, Geeta; Jebsen Centre for Cardiac Biomarkers, Division of Medicine, Department of Cardiology, Institute of Clinical Medicine, Oslo University Hospital, Ullevål, Oslo, Norway, 14 K.G ; University of Oslo, Oslo, Norway
Mirsadraee, Saeed; Department of Radiology, Royal Brompton Hospital, London, UK ; National Heart and Lung Institute, Imperial College London, London, UK
Sohaib Nazir, Muhammad; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK ; Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, UK
Lyon, Alexander; Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, UK
Stankovic, Ivan; Department of Cardiology, Faculty of Medicine, Clinical Hospital Centre Zemin, University of Belgrade, Belgrade, Serbia
Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC
Muhandiramge J, Zalcberg JR, van Londen GJ, Warner TE, Carr RP, Haydon A et al Cardiovascular disease in adult cancer survivors: a review of current evidence, strategies for prevention and management, and future directions for cardio-oncology. Curr Oncol Rep 2022; 24: 1579–92.
O’Neill C, Donnelly DW, Harbinson M, Kearney T, Fox RC, Walls G et al Survival of cancer patients with pre-existing heart disease. BMC Cancer 2022; 22: 847.
Ameri P, Bertero E, Lombardi M, Porto I, Canepa M, Nohria A et al Ischaemic heart disease in patients with cancer. Eur Heart J 2024; 45: 1209–23.
Stankovic I, Dweck MR, Marsan NA, Bergker-Klein J, Holte E, Manka R et al The EACVI survey on cardiac imaging in cardio-oncology. Eur Heart J Cardiovasc Imaging 2021; 22: 367–71.
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J et al 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43: 4229–361.
Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A et al Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk in Communities (ARIC) Study. J Am Coll Cardiol 2022; 80: 22–31.
Paterson DI, Wiebe N, Cheung WY, Mackey RJ, Pituskin E, Reiman A et al Incident cardiovascular disease among adults with cancer. JACC CardioOncol 2022; 4: 85–94.
Padegimas A, Carver JR. How to diagnose and manage patients with fluoropyrimidine-induced chest pain: a single center approach. JACC CardioOncol 2020; 2: 650–4.
Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 2000; 22: 263–302.
Lu Y, Pan W, Deng S, Dou Q, Wang X, An Q et al Redefining the incidence and profile of fluoropyrimidine-associated cardiotoxicity in cancer patients: a systematic review and meta-analysis. Pharmaceuticals (Basel) 2023; 16: 510.
El-Cheikh J, Moukalled N, Malard F, Bazarbachi A, Mohty M. Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies. Blood Cancer J 2023; 13: 83.
Medeiros BC, Possick J, Fradley M. Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: strategies for monitoring, detecting, and managing. Blood Rev 2018; 32: 289–99.
Levine GN, D’Amico AV, Berger P, Clark EP, Eckel HR, Keating LN et al Androgen-deprivation therapy in prostate cancer and cardiovascular risk. Circulation 2010; 121: 833–40.
Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L et al Prospective study of cardiac events during proteasome inhibitor therapy for relapsed multiple myeloma. J Clin Oncol 2019; 37: 1946–55.
Vallerio P, Orenti A, Tosi F, Maistrello M, Palazzini M, Cingarlini S et al Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management. ESMO Open 2021; 7: 100338.
Sara JD, Kaur J, Khodadadi R, Rehman M, Lobo R, Chakrabarti S et al 5-fluorouracil and cardiotoxicity: a review. Ther Adv Med Oncol 2018; 10:.
Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y et al Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 2016; 375: 1749–55.
Cautela J, Rouby F, Salem JE, Alexandre J, Scemama U, Dolladille C et al Acute coronary syndrome with immune checkpoint inhibitors: a proof-of-concept case and pharmacovigilance analysis of a life-threatening adverse event. Can J Cardiol 2020; 36: 476–81.
Hu YB, Zhang Q, Li HJ, Michot MJ, Liu BH, Zhan P et al Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res 2017; 6: S8–20.
Drobni ZD, Alvi RM, Taron J, Zafar A, Murphy SP, Rambarat PK et al Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation 2020; 142: 2299–311.
D’Souza M, Nielsen D, Svane IM, Iversen K, Rasmussen VP, Madelaire C et al The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study. Eur Heart J 2021; 42: 1621–31.
Laenens D, Yu Y, Santens B, Jacobs J, Beuselinck B, Bechter O et al Incidence of cardiovascular events in patients treated with immune checkpoint inhibitors. J Clin Oncol 2022; 40: 3430–8.
Polomski EAS, Kapiteijn EW, Heemelaar JC, van der Kolk AV, Kalisvaart TM, van de Burgt A et al Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I. Atherosclerosis 2024; 398: 118595.
O’Connor P, Laury R, Bhadbhade P, Khan Q, Williamson S. Acral vascular syndrome during an immune checkpoint inhibitor. BMJ Case Rep 2020; 13: e233463.
Cameron AC, McMahon K, Hall M, Neves BK, Rios JF, Montezano CA et al Comprehensive characterization of the vascular effects of cisplatin-based chemotherapy in patients with testicular cancer. JACC CardioOncol 2020; 2: 443–55.
Di Lisi D, Madonna R, Zito C, Bronte E, Badalamenti G, Parrella P et al Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond. Int J Cardiol 2017; 227: 11–7.
Touyz RM, Herrmann SM, Herrmann J. Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events. J Am Soc Hypertens 2018; 12: 409–17.
Lopes RD, Higano CS, Slovin SF, Nelson JA, Bigelow R, Sørensen S et al Cardiovascular safety of degarelix versus leuprolide in patients with prostate cancer: the primary results of the PRONOUNCE randomized trial. Circulation 2021; 144: 1295–307.
Nelson AJ, Lopes RD, Hong H, Hua K, Slovin S, Tan S et al Cardiovascular effects of GnRH antagonists compared with agonists in prostate cancer. JACC CardioOncol 2023; 5: 613–24.
Novo G, Di Lisi D, Bronte E, Macaione F, Accurso V, Badalamenti G et al Cardiovascular toxicity in cancer patients treated with tyrosine kinase inhibitors: a real-world single-center experience. Oncology 2020; 98: 445–51.
Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ. Raynaud’s phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 1981; 95: 288–92.
Lee C, Hahn RT. Valvular heart disease associated with radiation therapy: a contemporary review. Struct Heart 2022; 7: 100104.
Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L et al Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2013; 14: 721–40.
Yang EH, Marmagkiolis K, Balanescu DV, Hakeem A, Donisan T, Finch W et al Radiation-induced vascular disease-a state-of-the-art review. Front Cardiovasc Med 2021; 8: 652761.
Bergom C, Bradley JA, Ng AK, Samson P, Robinson C, Mattei LJ et al Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification. JACC CardioOncol 2021; 3: 343–59.
Gal R, van Velzen SGM, Hooning MJ, Emaus MJ, Van der Leij F, Gregorowitsch M et al Identification of risk of cardiovascular disease by automatic quantification of coronary artery calcifications on radiotherapy planning CT scans in patients with breast cancer. JAMA Oncol 2021; 7: 1024–32.
Lopez-Mattei J, Yang EH, Baldassarre LA, Agha A, Blankstein R, Choi DA et al Cardiac computed tomographic imaging in cardio-oncology: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS). J Cardiovasc Comput Tomogr 2023; 17: 66–83.
Shen H, Lian Y, Yin J, Zhi M, Yang C, Tu C et al Cardiovascular risk stratification by automatic coronary artery calcium scoring on pretreatment chest computed tomography in diffuse large B-cell lymphoma receiving anthracycline-based chemotherapy: a multicenter study. Circ Cardiovasc Imaging 2023; 16: e014829.
Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J 2024; 45: 3415–537.
Taylor AJ, Cerqueira M, Hodgson JMB, Mark D, Min J, O'Gara P et al ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2010; 56: 1864–94.
Golub IS, Termeie OG, Kristo S, Schroeder PL, Lakshmanan S, Shafter MA et al Major global coronary artery calcium guidelines. JACC Cardiovasc Imaging 2023; 16: 98–117.
Mitchell JD, Fergestrom N, Gage BF, Paisley R, Moon P, Novak E et al Impact of statins on cardiovascular outcomes following coronary artery calcium scoring. J Am Coll Cardiol 2018; 72: 3233–42.
Prati F, Biccirè FG. Plaque vulnerability: looking up beyond risk factors. Atherosclerosis 2023; 378: 117159.
Leiva O, AbdelHameid D, Connors JM, Cannon CP, Bhatt DL. Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 2021; 3: 619–34.
Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A et al 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44: 3720–826.
Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P et al Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. Eur Heart J Acute Cardiovasc Care 2021; 10: 947–59.
Nazir MS, Murphy T, Poku N, Wheen P, Nowbar NA, Andres SM et al Clinical utility and prognostic value of coronary computed tomography angiography in patients with cancer. Am J Cardiol 2023; 207: 448–54.
Baldassarre LA, Ganatra S, Lopez-Mattei J, Yang HA, Zaha GV, Wong CT et al Advances in multimodality imaging in cardio-oncology: JACC state-of-the-art review. J Am Coll Cardiol 2022; 80: 1560–78.
Osterlund P, Kinos S, Pfeiffer P, Salminen T, Kwakman MJJ, Frödin EJ et al Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. ESMO Open 2022; 7: 100427.
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi JY et al International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018; 39: 2032–46.
Totzeck M, Aide N, Bauersachs J, Bucerius J, Georgoulias P, Herrmann K et al Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging 2023; 50: 792–812.
Edvardsen T, Asch FM, Davidson B, Delgado V, DeMaria A, Dilsizian V et al Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Eur Heart J Cardiovasc Imaging 2022; 23: e6–33.
Tong J, Vogiatzakis N, Andres MS, Senechal I, Badr A, Ramalingam S et al Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis. Cardiooncology 2024; 10: 53.
SCOT-HEART Investigators; Newby DE, Adamson PD, Boon AN, Dweck RM, Flather M et al Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 2018; 379: 924–33.
Williams MC, Kwiecinski J, Doris M, McElhinney P, D’Souza SM, Cadet S et al Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction. Circulation 2020; 141: 1452–62.
Chan K, Wahome E, Tsiachristas A, Antonopoulos SA, Patel P, Lyasheva M et al Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet 2024; 403: 2606–18.
Lopez-Mattei JC, Yang EH, Ferencik M, Baldassarre LA, Dent S, Budoff MJ. Cardiac computed tomography in cardio-oncology: JACC: CardioOncology primer. JACC CardioOncol 2021; 3: 635–49.
Sharma SP, Lemmens MJDK, Smulders MW, Budde RPJ, Hirsch A, Mihl C. Photon-counting detector computed tomography in cardiac imaging. Neth Heart J 2024; 32: 405–16.
Novo G, Santoro C, Manno G, Lisi D, Esposito R, Mandoli EG et al Usefulness of stress echocardiography in the management of patients treated with anticancer drugs. J Am Soc Echocardiogr 2021; 34: 107–16.
Antonopoulos AS, Vrettos A, Androulakis E, Kamperou C, Vlachopoulos C, Tsioufis K et al Cardiac magnetic resonance imaging of pericardial diseases: a comprehensive guide. Eur Heart J Cardiovasc Imaging 2023; 24: 983–98.
Greenwood JP, Maredia N, Younger JF, Brown MJ, Nixon J, Everett C et al Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012; 379: 453–60.
Heitner JF, Kim RJ, Kim HW, Klem I, Shah J, Debs D et al Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48 000 patient-years of follow-up. JAMA Cardiol 2019; 4: 256–64.
Kwong RY, Ge Y, Steel K, Bingham S, Abdullah S, Fujikura K et al Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain. J Am Coll Cardiol 2019; 74: 1741–55.
Kotecha T, Chacko L, Chehab O, O’Reilly N, Martinez-Naharro A, Lazari J et al Assessment of multivessel coronary artery disease using cardiovascular magnetic resonance pixelwise quantitative perfusion mapping. JACC Cardiovasc Imaging 2020; 13: 2546–57.
Petretta M, Storto G, Pellegrino T, Bonaduce D, Cuocolo A. Quantitative assessment of myocardial blood flow with SPECT. Prog Cardiovasc Dis 2015; 57: 607–14.
Pontone G, Rossi A, Guglielmo M, Dweck MR, Gaemperli O, Nieman K et al Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II. Eur Heart J Cardiovasc Imaging 2022; 23: e136–61.
Pontone G, Baggiano A, Andreini D, Guaricci AI, Guglielmo M, Muscogiuri G et al Dynamic stress computed tomography perfusion with a whole-heart coverage scanner in addition to coronary computed tomography angiography and fractional flow reserve computed tomography derived. JACC Cardiovasc Imaging 2019; 12: 2460–71.
Pepine CJ, Anderson RD, Sharaf BL, Reis RS, Smith MK, Handberg ME et al Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010; 55: 2825–32.
Divakaran S, Caron JP, Zhou W, Hainer J, Bibbo FC, Skali H et al Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer. J Nucl Cardiol 2022; 29: 3072–81.
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M et al 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016; 37: 2768–801.
Morbidelli L, Donnini S, Ziche M. Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents. Cardiooncology 2016; 2: 3.
Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X et al Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. Lancet Oncol 2013; 14: 933–42.
Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G et al The vascular endothelium and human diseases. Int J Biol Sci 2013; 9: 1057–69.
Hamo CE, Bloom MW. Getting to the heart of the matter: an overview of cardiac toxicity related to cancer therapy. Clin Med Insights Cardiol 2015; 9: 47–51.
Venkatesulu BP, Mahadevan LS, Aliru ML, Yang X, Bodd HM, Singh KP et al Radiation-induced endothelial vascular injury: a review of possible mechanisms. JACC Basic Transl Sci 2018; 3: 563–72.
Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL, Camici PG, Chilian WM et al Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation 2017; 135: 1075–92.
Zhang J, Ma M, Li H, Pu Z, Liu H, Huang T et al Early diagnosis of coronary microvascular dysfunction by myocardial contrast stress echocardiography. Math Biosci Eng 2023; 20: 7845–58.
Chiribiri A, Arai AE, DiBella E, Hsu LY, Ishida M, Jerosch-Herold M et al Society for cardiovascular magnetic resonance expert consensus statement on quantitative myocardial perfusion cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson 2025; 27: 101940.
Rahman H, Scannell CM, Demir OM, Ryan M, McConkey H, Ellis H et al High-resolution cardiac magnetic resonance imaging techniques for the identification of coronary microvascular dysfunction. JACC Cardiovasc Imaging 2021; 14: 978–86.
Maddahi J, Packard RRS. Cardiac PET perfusion tracers: current status and future directions. Semin Nucl Med 2014; 44: 333–43.
Schindler TH, Nitzsche EU, Olschewski M, Brink I, Mix M, Prior J et al PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. J Nucl Med 2004; 45: 419–28.
Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow JWB, Renaud MJ et al Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011; 58: 740–8.
Dubec JJ, Munk PL, Tsang V, Lee MJ, Janzen DL, Buckley J et al Carotid artery stenosis in patients who have undergone radiation therapy for head and neck malignancy. Br J Radiol 1998; 71: 872–5.
Gujral DM, Chahal N, Senior R, Harrington KJ, Nutting CM. Radiation-induced carotid artery atherosclerosis. Radiother Oncol 2014; 110: 31–8.
Virmani R, Farb A, Carter AJ, Jones RM. Pathology of radiation-induced coronary artery disease in human and pig. Cardiovasc Radiat Med 1999; 1: 98–101.
Rucher G, Prigent K, Simard C, Frelin MA, Coquemont-Guyot M, Elie N et al Targeted radiation exposure induces accelerated aortic valve remodeling in ApoE−/− mice. J Clin Med 2023; 12: 5854.
Kawatani Y, Kurobe H, Nakamura Y, Suda Y, Hori T. Aortic rupture due to radiation injury successfully treated with thoracic endovascular aortic repair. J Surg Case Rep 2017; 2017: rjx092.
Will JA, Bindi JM, Crawford JL, West CA, Deitch JS. Chronic abdominal aortic occlusion in a patient with an underdeveloped, irradiated pelvis after childhood treatment of Ewing Sarcoma. J Vasc Surg Cases Innov Tech 2024; 10: 101380.
Moudgil R, Yeh ETH. Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: cardiomyopathy and beyond. Can J Cardiol 2016; 32: 863–70.e5.
Trojanowski P, Sojka M, Trojanowska A, Wolski A, Roman T, Jargiello T. Management of radiation induced carotid stenosis in head and neck cancer. Transl Oncol 2019; 12: 1026–31.
Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M et al 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J 2024; 45: 3538–700.
Johri AM, Nambi V, Naqvi TZ, Feinstein BS, Kim SHE, Park MM et al Recommendations for the assessment of carotid arterial plaque by ultrasound for the characterization of atherosclerosis and evaluation of cardiovascular risk: from the American Society of Echocardiography. J Am Soc Echocardiogr 2020; 33: 917–33.
Tartari S, Rizzati R, Righi R, Deledda A, Capello K, Soverini R et al High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography: one-stop shopping for the comprehensive assessment of carotid atherosclerosis. Am J Roentgenol 2011; 196: 1164–71.
Saxena A, Ng EYK, Lim ST. Imaging modalities to diagnose carotid artery stenosis: progress and prospect. Biomed Eng Online 2019; 18: 66.
